ERBB2 c.776A>G ;(p.N259S)

Variant ID: 17-37866609-A-G

NM_004448.2(ERBB2):c.776A>G;(p.N259S)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Advantages and Limitations of Monitoring Circulating Tumor DNA Levels to Predict the Prognosis of Patients Diagnosed With Gastric Cancer.

Biomarker Insights
He, Wan W; Yang, Jingxin J; Sun, Xiao X; Jiang, Shunda S; Jiang, Jinchan J; Liu, Ming M; Mu, Tianhao T; Li, Yingmei Y; Zhang, Xiaoni X; Duan, Jingxian J; Xu, Ruilian R
Publication Date: 2022

Variant appearance in text: ERBB2: 776A>G; N259S
PubMed Link: 36533271
Variant Present in the following documents:
  • sj-xlsx-2-bmi-10.1177_11772719221141525.xlsx, sheet 1
View BVdb publication page



Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.

Cell Reports. Medicine
Hurst, Carolyn D CD; Cheng, Guo G; Platt, Fiona M FM; Castro, Mauro A A MAA; Marzouka, Nour-Al-Dain S NS; Eriksson, Pontus P; Black, Emma V I EVI; Alder, Olivia O; Lawson, Andrew R J ARJ; Lindskrog, Sia V SV; Burns, Julie E JE; Jain, Sunjay S; Roulson, Jo-An JA; Brown, Joanne C JC; Koster, Jan J; Robertson, A Gordon AG; Martincorena, Inigo I; Dyrskjøt, Lars L; Höglund, Mattias M; Knowles, Margaret A MA
Publication Date: 2021-12-21

Variant appearance in text: ERBB2: N259S
PubMed Link: 35028613
Variant Present in the following documents:
  • mmc1.pdf
  • mmc7.pdf
View BVdb publication page